BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 3801953)

  • 1. A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin.
    Ohmatsu H; Eguchi K; Shinkai T; Tamura T; Ohe Y; Nisio M; Kunikane H; Arioka H; Karato A; Nakashima H
    Jpn J Cancer Res; 1994 Nov; 85(11):1151-8. PubMed ID: 7829401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research].
    Du Bois A
    Med Klin (Munich); 1998 Jan; 93 Suppl 1():3-17. PubMed ID: 19479418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives in antiemetic treatment.
    Herrstedt J
    Support Care Cancer; 1996 Nov; 4(6):416-9. PubMed ID: 8961471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The control of acute cisplatin-induced emesis--a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Granisetron Study Group.
    Chevallier B
    Br J Cancer; 1993 Jul; 68(1):176-80. PubMed ID: 8391304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities.
    Del Favero A; Roila F; Tonato M
    Drug Saf; 1993 Dec; 9(6):410-28. PubMed ID: 7510495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the correlation of serum metoclopramide levels with antiemetic efficacy in patients receiving cisplatin.
    Grunberg SM; McDermed JE; Bernstein L; Cohen JL
    Cancer Chemother Pharmacol; 1987; 20(4):332-6. PubMed ID: 3690807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropharmacology of emesis in relation to clinical response.
    Costall B; Naylor RJ
    Br J Cancer Suppl; 1992 Dec; 19():S2-7; discussion S7-8. PubMed ID: 1467196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent improvements in antiemetic therapy].
    Roila F; Palladino MA; Ciccarese G; Basurto C
    Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination antiemetics for cisplatin chemotherapy.
    Sridhar KS; Donnelly E
    Cancer; 1988 Apr; 61(8):1508-17. PubMed ID: 3280112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis.
    Grunberg SM; Akerley WL; Krailo MD; Johnson KB; Baker CR; Cariffe PA
    Cancer Invest; 1986; 4(5):379-85. PubMed ID: 3801953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
    J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination metoclopramide and dexamethasone: an effective antiemetic regimen in outpatients receiving non-cisplatin chemotherapy.
    Strum SB; McDermed JE; Streng BR; McDermott NM
    J Clin Oncol; 1984 Sep; 2(9):1057-63. PubMed ID: 6470755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
    Kris MG; Gralla RJ; Clark RA; Tyson LB; Groshen S
    Cancer; 1987 Dec; 60(11):2816-22. PubMed ID: 3315176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.